Post Marketing Information PEM 19/05/2025 SOLIRIS® (eculizumab): Guide for Healthcare Professionals PMG 19/05/2025 SOLIRIS® (eculizumab): Guide for Patients/Parents/Caregivers PAC 19/05/2025 SOLIRIS® PATIENT CARD: Important Safety Information for Patients Taking SOLIRIS® (eculizumab)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Soliris Infusion, Solution Concentrate 300 mg/vial National University Hospital
INTRAVENOUS Select a brand starting with the letter: S SOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL [SIN14226P]